Oxford Gene Technology in Collaboration with Optra Systems to Develop Analysis Software
News Feb 27, 2009
Oxford Gene Technology (OGT) has announced a collaboration with Optra Systems, a Life Science and Healthcare IT consultancy company with expertise in biomedical imaging, to develop visualization and analysis software.
The collaboration was established to develop software to visualize and analyze data generated from high resolution scanners. The project is now in the testing phase following initial software development.
“We are developing an exciting portfolio of technologies to enable researchers to investigate gene expression in single cells,” said Dr John Anson, OGT’s R&D Director. “Image analysis is an integral part of these developments, and we chose Optra Systems for its expertise and excellent service. We are evaluating outsourcing opportunities for a further pilot project to develop a more powerful version of the software, and look forward to continuing our relationship with Optra Systems.”
Abhi Gholap, President and CEO of Optra Systems, said: “This is an exciting time for Optra Systems. Our biomedical imaging and application development expertise is well suited to building a powerful software analysis solution for the innovative platform in development at OGT, and we look forward to taking the project into the next phase.”
Neuroblastoma Biomarker Research Advances TreatmentNews
Neuroblastoma, a childhood cancer, is treatable in less than half of aggressive cases, but new RNA biomarkers may help identify high-risk patients faster and lead to better prognosis.READ MORE
The Exercise Regime of the Future Needs to Check Your GenesNews
Forget protein bars - genes may be central to the exercise regimes of the future, as scientists track down gene changes which occur in response to exercise.READ MORE